REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Novomed OOO (Moscow) (Новомед ООО (Москва)) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Novomed OOO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Novomed OOO (Moscow) (Новомед ООО (Москва)) is a company in Russia, with a head office in Moscow. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on November 10, 2002. The company’s latest financial report indicates a net sales revenue increase of 19.27% in 2024. Its total assets grew by 7.43% over the same period. The net profit margin of Novomed OOO (Moscow) (Новомед ООО (Москва)) decreased by 2.13% in 2024.

Headquarters
Bolishaya Serpuhovskaya, 31, 5, 3P
Moscow; Moscow; Postal Code: 115093

Contact Details: Purchase the Novomed OOO (Moscow) (Новомед ООО (Москва)) report to view the information.

Basic Information
Registered Capital:
Purchase the Novomed OOO (Moscow) (Новомед ООО (Москва)) report to view the information.
Financial Auditors:
Purchase the Novomed OOO (Moscow) (Новомед ООО (Москва)) report to view the information.
Incorporation Date:
November 10, 2002
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
96%
Purchase this report to view the information.
2%
Purchase this report to view the information.
2%
Company Performance
Financial values in the chart are available after Novomed OOO (Moscow) (Новомед ООО (Москва)) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
19.27%▲
Total operating revenue
19.27%▲
Operating profit (EBIT)
15.7%▲
Net Profit (Loss) for the Period
10%▲
Total Assets
7.43%▲
Total Equity
8.77%▲
Operating Profit Margin (ROS)
-0.85%▼
Net Profit Margin
-2.13%▼
Return on Equity (ROE)
0.25%▲
Quick Ratio
5.86%▲
Cash Ratio
-1.09%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo